1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization : a European multinational economic evaluation
(
- Contribution to journal › Article
- 2021
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure : the results of the AFFIRM-AHF study
(
- Contribution to journal › Article
- 2020
-
Mark
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
(
- Contribution to journal › Article
- 2019
-
Mark
Rationale and design of the AFFIRM-AHF trial : a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure
(
- Contribution to journal › Article
- 2015
-
Mark
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
(
- Contribution to journal › Article
- 2013
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
(
- Contribution to journal › Article
-
Mark
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
(
- Contribution to journal › Article
- 2011
-
Mark
Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial
(
- Contribution to journal › Article
- 2009
-
Mark
Rationale and design of Ferinject((R)) Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
(
- Contribution to journal › Article
-
Mark
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
(
- Contribution to journal › Article